- Home
- HUIZ vs ABVC Comparison
HUIZ vs ABVC Comparison
Compare HUIZ & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- ABVC
- Stock Information
- Founded
- HUIZ 2006
- ABVC 2015
- Country
- HUIZ China
- ABVC United States
- Employees
- HUIZ N/A
- ABVC N/A
- Industry
- HUIZ Specialty Insurers
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- ABVC Health Care
- Exchange
- HUIZ Nasdaq
- ABVC Nasdaq
- Market Cap
- HUIZ 18.8M
- ABVC 22.1M
- IPO Year
- HUIZ 2020
- ABVC N/A
- Fundamental
- Price
- HUIZ N/A
- ABVC $3.15
- Analyst Decision
- HUIZ Hold
- ABVC
- Analyst Count
- HUIZ 1
- ABVC 0
- Target Price
- HUIZ $2.30
- ABVC N/A
- AVG Volume (30 Days)
- HUIZ 18.5K
- ABVC 436.6K
- Earning Date
- HUIZ 06-06-2025
- ABVC 08-13-2025
- Dividend Yield
- HUIZ N/A
- ABVC N/A
- EPS Growth
- HUIZ N/A
- ABVC N/A
- EPS
- HUIZ N/A
- ABVC N/A
- Revenue
- HUIZ $168,454,627.00
- ABVC $508,383.00
- Revenue This Year
- HUIZ $11.94
- ABVC $735.18
- Revenue Next Year
- HUIZ $8.15
- ABVC N/A
- P/E Ratio
- HUIZ N/A
- ABVC N/A
- Revenue Growth
- HUIZ 1.28
- ABVC 1904.43
- 52 Week Low
- HUIZ $1.50
- ABVC $0.40
- 52 Week High
- HUIZ $10.58
- ABVC $3.12
- Technical
- Relative Strength Index (RSI)
- HUIZ 42.00
- ABVC 69.63
- Support Level
- HUIZ $1.97
- ABVC $2.16
- Resistance Level
- HUIZ $2.12
- ABVC $3.10
- Average True Range (ATR)
- HUIZ 0.10
- ABVC 0.26
- MACD
- HUIZ -0.01
- ABVC 0.09
- Stochastic Oscillator
- HUIZ 5.80
- ABVC 85.29
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.